Top of this page
Skip navigation, go straight to the content

Newsroom February 2016

Briviact®

in the US, Briviact® (brivaracetam) is indicated as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy

 

 


February, 2016

Briviact US

In Focus archive